International Journal of New Chemistry
ISC, DOAJ, CAS, Google Scholar......

Innovative Drug Delivery Systems: Nanotechnology in Medicine

Document Type : Review

Author

Mitra Akbari

Eye Research Center, Department of Eye, Amiralmomenin Hospital, School of Medicine, Guilan University of Medical Science, Rasht, Iran

10.22034/ijnc.2025.721811
Abstract
Nanotechnology has emerged as a transformative force in modern medicine, offering innovative solutions to longstanding challenges in drug delivery. This review explores the advancements and applications of nanotechnology-based drug delivery systems, emphasizing their potential to enhance therapeutic efficacy, minimize side effects, and improve patient outcomes. Key topics include the design and engineering of nanoparticles, liposomes, dendrimers, and polymeric systems that facilitate targeted delivery, controlled release, and increased bioavailability of drugs. The paper also examines the role of nanocarriers in addressing complex medical conditions such as cancer, neurodegenerative diseases, and infectious disorders. Furthermore, it highlights the challenges associated with clinical translation, including biocompatibility, scalability, and regulatory considerations. By synthesizing recent developments and identifying future directions, this review underscores the pivotal role of nanotechnology in revolutionizing drug delivery systems and advancing precision medicine.

Keywords

Nanotechnology
Drug delivery systems
Innovative medicine
Targeted therapy
Biomedical applications
Subjects
  1. Sahiner, A. Pezeshk, L. M. Hadjiiski, et al., Med. Phys. 46, 1 (2019).
  2. S. O. Pijeira, H. Viltres, J. Kozempel, et al., EJNMMI Radiopharm. Chem. 7, 8 (2022).
  3. A. Westcott, D. M. Coldwell, D. M. Liu, et al., Adv. Radiat. Oncol. 1, 351 (2016).
  4. M. Ariel and G. T. Pack, Thoraxchir. Vask. Chir. 14, 286 (1966).
  5. Simon, R. Siffert, M. G. Baron, et al., Cancer 21, 453 (1968).
  6. L. Volchok and J. L. Kulp, Phys. Rev. 97, 102 (1955).
  7. Saini, A. Wallace, S. Alzubaidi, et al., J. Clin. Med. 8, 55 (2019).
  8. Gray, US Patent No. 11743530 (P.A.P., 2007), No. 11, p. 6.
  9. J. Ehrhardt and D. E. Day, Int. J. Radiat. Appl. Instrum., Part B 14, 233 (1987).
  10. Harada, S. Ehara, K. Ishii, et al., Int. J. Radiat. Oncol. Biol. Phys. 75, 455 (2009).
  11. Madani, S. S. Esnaashari, T. J. Webster, et al., J. Control. Release 349, 649 (2022).
  12. Blanco, H. Shen, and M. Ferrari, Nat. Biotechnol. 33, 941 (2015).
  13. Yugui, H. Wang, D. Sun, et al., Biomed. Pharmacother. 114, 108820 (2019).
  14. Tadros, P. Izquierdo, J. Esquena, et al., Adv. Colloid Interface Sci. 108, 303 (2004).
  15. Fraga, R. S. Schuh, É. Poletto, et al., Curr. Gene Ther. 21, 464 (2021).
  16. B. Đoković, S. Demisli, S. Savić, et al., Pharm. 14, 1666 (2022).
  17. N. Harun, S. A. Nordin, S. S. A. Gani, et al., Int. J. Nanomed., 2571 (2018).
  18. Ahmad, R. El Sadda, G. Botchkina, et al., Cancer Lett. 406, 71 (2017).
  19. B. Mirgorodskaya, M. Y. Koroleva, R. A. Kushnazarova, et al., Nanotechnology 33, 155103 (2022).
  20. Jagdale, M. Narwade, A. Sheikh, et al., Int. J. Pharm. 637, 122894 (2023).
  21. Aly, A. H. El-Kamel, E. Sheta, et al., Int. J. Pharm. 637, 123163 (2023).
  22. Shirvani, S. A. H. Goli, J. Varshosaz, et al., J. Dispers. Sci. Technol. 44, 1809 (2023).
  23. Khosa, S. Reddi, and R. N. Saha, Biomed. Pharmacother. 103, 598 (2018).
  24. I. Higuchi and J. Misra, J. Pharm. Sci. 51, 459 (1962).
  25. Y. Koroleva and E. V. Yurtov, Russ. Chem. Rev. 90, 293 (2021).
  26. J. McClements and S. M. Jafari, in Nanoemulsions: Formulation, Applications, and Characterization(Academic, New York, 2018), Chap. 1, p. 3.
  27. Y. Koroleva and E. V. Yurtov, Russ. Chem. Rev. 81, 21 (2012).
  28. Koroleva, I. Portnaya, E. Mischenko, et al., J. Colloid Interface Sci. 610, 61 (2022).
  29. Koroleva, Phys. Chem. Chem. Phys. 25, 21836 (2023).
  30. M. Alshahrani, J. Drug Deliv. Sci. Technol. 68, 103085 (2022).
  31. A. Joshi, R. S. Patwardhan, D. Sharma, et al., Int. J. Pharm. 595, 120181 (2021).
  32. Adhikari and R. Arora, Mutat. Res. Genet. Toxicol. Environ. Mutagen. 792, 1 (2015).
  33. Youshia, A. O. Kamel, and A. El Shamy, Eur. J. Pharm. Sci. 163, 105887 (2021).
  34. S. Patil, K. Prabhakaran, C. Durgaprasad, et al., Ceram. Int. 35, 515 (2009).
  35. Izquierdo, J. Feng, J. Esquena, et al., J. Colloid Interface Sci. 285, 388 (2005).
  36. Y. Koroleva, T. Y. Nagovitsina, and E. V. Yurtov, Mendeleev Commun. 25, 389 (2015).
  37. V. Zotova, V. V. Arslanov, and I. A. Gagina, Thin Solid Films 326, 223 (1998).
  38. D. Shirokikh, V. A. Anikina, E. A. Zamyatina, et al., Nanosyst.: Phys. Chem. Math. 14, 89 (2023).
  39. Y. Koroleva and E. V. Yurtov, Russ. Chem. Rev. 91, RCR5024 (2022).
  40. Hickey, M. F. Mulcahy, R. J. Lewandowski, et al., Int. J. Radiat. Oncol. Biol. Phys. 88, 1025 (2014).
  41. ISO 11137-2:2013: Sterilization of health care products - Radiation - Part 2: Establishing the sterilization dose.
International Journal of New Chemistry
Volume 12, Issue 4
Winter 2025
Pages 856-873

Home

Reviewers